-
Mashup Score: 53HHS fills key vaccine advisory panel slots - 2 month(s) ago
HHS is filling eight vacancies on an important vaccine advisory panel after STAT reported on the panel having so many open positions.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 53HHS fills key vaccine advisory panel slots - 2 month(s) ago
HHS is filling eight vacancies on an important vaccine advisory panel after STAT reported on the panel having so many open positions.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Good news on the #ACIP front. @HHSGov has approved new members to fill all those vacancies. https://t.co/mEIoHEanfj
-
-
Mashup Score: 12
With last fall’s early start to the respiratory virus season still fresh in the public memory, health authorities are trying to move quickly to convey the impression that this year will be different.
Source: www.statnews.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
US health authorities want to convey a message about the looming arrival of #RSV, #flu & probably more #Covid: We're on it! #ACIP meets Sept 12 to review new Covid boosters; they should be available soon after. https://t.co/jjsTDWhTdS
-
-
Mashup Score: 49
A panel of advisers to the CDC unanimously voted Thursday to recommend wide use among infants and some high-risk children of an antibody designed to protect against RSV.
Source: www.statnews.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@CDCgov's vaccine advisory committee, #ACIP, voted today to recommend use of AstraZeneca & Sanofi's Beyfortus, a monoclonal antibody to protect babies against #RSV. Could be a gamechanger. @Jasonmmast reports. https://t.co/g6DZXdz6P3
-
-
Mashup Score: 66
The FDA approved a monoclonal antibody to protect infants and young children from severe illness caused by RSV on Monday, a potential game-changer for the disease.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
This could be a game changer for a dreadful disease that affects young children. @US_FDA has approved Beyfortus, the AstraZeneca/Sanofi monoclonal to protect against severe #RSV infection in babies. #ACIP meets on this on Aug. 3. https://t.co/xmXKLRhGvr
-
-
Mashup Score: 2Updates from June 2023 Advisory Committee on Immunization Practices (ACIP) Meeting - 10 month(s) ago
NFID webinar will cover updates from the June 21-23, 2023, Advisory Committee on Immunization Practices (ACIP) meeting
Source: NFIDCategories: Infectious Disease, Latest HeadlinesTweet-
Join @NFIDVaccines on July 12th at 12:00 pm ET for a discussion highlighting updates from the June 21-23, 2023, Advisory Committee on Immunization Practices (ACIP) meeting on US #vaccination recommendations for children, adolescents, and adults. #ACIP https://t.co/ZZG1wq9xWs
-
-
Mashup Score: 1
The RSVpreF vaccine for pregnant women and monoclonal antibody nirsevimab for infants have the potential for federal approval in the coming months, but experts are continuing to grapple with unanswered questions and logistical hurdles.
Source: American Academy of PediatricsCategories: Latest Headlines, PediatricsTweet-
Two products to protect infants from RSV have the potential for federal approval in the coming months. However, experts are continuing to grapple with unanswered questions and logistical hurdles. #ACIP https://t.co/BNfhugMUNB
-
-
Mashup Score: 6CDC advisory panel recommends seniors 'may' get RSV vaccine - 10 month(s) ago
If endorsed by CDC director Rochelle Walensky, the recommendation may lead to lower uptake than vaccine makers had hoped.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
#ACIP foregoes a stronger "should" recommendation, votes that adults 60 & older "may" get an #RSV vaccine if they & their health-care provider deem it of value to them. This would not have been the recommendation #GSK & #Pfizer were hoping for. https://t.co/XsZJt57MVq
-
-
Mashup Score: 0Quick takes: Chikungunya vaccine trial, Nipah research partnership, CDC vaccine advisers to meet - 10 month(s) ago
ACIP topics include RSV, flu, polio, mpox, meningococcal, and COVID-19 vaccines.
Source: www.cidrap.umn.eduCategories: Infectious Disease, Latest HeadlinesTweet-
Quick takes: Chikungunya vaccine trial, Nipah research partnership, CDC vaccine advisers to meet #ACIP topics include RSV, flu, polio, mpox, meningococcal, and #COVID19 vaccines https://t.co/pnLr6Uyfw3
-
-
Mashup Score: 31FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV - 11 month(s) ago
An FDA advisory committee voted overwhelmingly to recommend approval of a monoclonal antibody product to protect newborns and young children from RSV.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
An @US_FDA advisory c'tee voted to recommend use of AstraZeneca & Sanofi nirsevimab to protect young kids from #RSV. The full day meeting was about safety & efficacy; debate about costs & implementation challenges will come when this gets to #ACIP. https://t.co/DbZy52yumb
-
Good news on the #ACIP front. @HHSGov has approved new members to fill all those vacancies. https://t.co/mEIoHEanfj